Cited 3 times in

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology

DC Field Value Language
dc.contributor.author김영한-
dc.date.accessioned2020-09-28T02:09:09Z-
dc.date.available2020-09-28T02:09:09Z-
dc.date.issued2020-03-
dc.identifier.issn2287-8572-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179063-
dc.description.abstractBased on emerging data and current knowledge regarding high-risk human papillomavirus (hrHPV) testing as a primary screening for cervical cancer, the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology support the following scientific facts: • Compared to cytology, hrHPV screening has higher sensitivity and detects more cases of high-grade cervical intraepithelial neoplasia. • Qualified hrHPV testing can be considered as an alternative primary screening for cervical cancer to the current cytology method. • The starting age of primary hrHPV screening should not be before 25 years because of possible overtreatment in this age, which has a high human papillomavirus (HPV) prevalence but rarely progresses to cancer. The screening interval should be no sooner than every 3 years and no longer than every 5 years. • Before the introduction of hrHPV screening in Korea, research into comparative effectiveness of primary hrHPV screening for cervical cancer should be conducted to determine the appropriate HPV assay, starting age, and screening interval.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Society of Obstetrics and Gynecology-
dc.relation.isPartOfObstetrics & Gynecology Science-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleHigh-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.googleauthorTae-Wook Kong-
dc.contributor.googleauthorMiseon Kim-
dc.contributor.googleauthorYoung-Han Kim-
dc.contributor.googleauthorYong Beom Kim-
dc.contributor.googleauthorJayeon Kim-
dc.contributor.googleauthorJae-Weon Kim-
dc.contributor.googleauthorMi Hye Park-
dc.contributor.googleauthorJoo Hyun Park-
dc.contributor.googleauthorJeong Ho Rhee-
dc.contributor.googleauthorMyong Cheol Lim-
dc.contributor.googleauthorJoon-Seok Hong-
dc.contributor.googleauthoron behalf of Korean Society of Obstetrics and Gynecology developed by Position Statement Writing Committee-
dc.identifier.doi10.5468/ogs.2020.63.2.107-
dc.contributor.localIdA00730-
dc.relation.journalcodeJ02408-
dc.identifier.eissn2287-8580-
dc.identifier.pmid32206648-
dc.subject.keywordCancer screening tests-
dc.subject.keywordHuman papillomavirus DNA tests-
dc.subject.keywordUterine cervical neoplasms-
dc.contributor.alternativeNameKim, Young Han-
dc.contributor.affiliatedAuthor김영한-
dc.citation.volume63-
dc.citation.number2-
dc.citation.startPage107-
dc.identifier.bibliographicCitationObstetrics & Gynecology Science, Vol.63(2) : 107, 2020-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.